Groenhuysen Wilhelmus CM's Form 4 filing
NovoCure Ltd (NVCR) · filed Mar 5, 2024
- Accession no.
- 0001562180-24-002248
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $53.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Groenhuysen Wilhelmus CMCIK 0001264783 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Ordinary Shares | SSaleDisposed | −2,107 | $16.03 | −$33,775.21 | 252,452 | Direct | |
| Mar 4, 2024 | Ordinary Shares | SSaleDisposed | −1,217 | $16.01 | −$19,484.17 | 251,235 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.